4KG-31705-45257
4 vaccinations
3 coded responses
50 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 605 / IL
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Registered in v-safe
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-06
- 2021-04-07
- 2021-04-09
- 2021-04-15
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
-
2021-05-28
Survey response — day 35, dose 2MedDRA: Abdominal pain lower — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Lower abdominal painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-04
- 2021-07-23
- 2021-10-22
-
2021-11-19
Dose 3 — Pfizer-BioNTech
-
2021-11-19
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-25
- 2021-11-27
- 2021-12-03
- 2021-12-10
-
2021-12-17
Survey response — day 28, dose 3MedDRA: Haemorrhoids, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Hemorroid (never had it before) · Healthcare visit (other): Doctor appointmentMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Report sent to call center — day 28, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2021-12-21
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-12-24
- 2022-01-02
- 2022-02-18
- 2022-05-20
-
2022-11-15
Dose 4 — Pfizer-BioNTech
- 2022-11-15
- 2022-11-16
- 2022-11-17
- 2022-11-18
- 2022-11-19
- 2022-11-20
- 2022-11-22
-
2022-11-29
Survey response — day 14, dose 4MedDRA: Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: FairFree text: Sore throat, congestion, runny nose. Covid test negativeMedDRA releases: 2024-11 · check-in free text available
- 2022-12-06
- 2022-12-13
- 2022-12-20
- 2022-12-29
- 2023-02-14
- 2023-05-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Pfizer-BioNTech | No |
| 4 | 2022-11-15 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-17 | Successful 2021-12-21 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 8 — day 35, dose 2
Symptoms: Lower abdominal pain
Release 10 — day 28, dose 3
Release 12 — day 14, dose 4
Symptoms: Sore throat, congestion, runny nose. Covid test negative
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abdominal pain lower | ✓ | ✓ | ✓ |
| SD | Haemorrhoids | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release